Blog
New Diversity, Equity and Inclusion changes to the Actuaries’ Code and Guidance
Jenny Higgins
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has selected Harwell, as the location for its Moderna Innovation and Technology Centre (MITC).
The MITC development will encompass a research, development and manufacturing facility, providing the UK public with access to cutting-edge mRNA vaccines for a wide range of respiratory diseases, pending regulatory assessment and licensure. The MITC will also include a clinical biomarker laboratory - a prefabricated modular laboratory constructed in Northumberland which will then be installed on the campus.
The Kingsley Napley team was led by Peter Metcalfe, a Partner in the Real Estate & Construction Team, with assistance from Associate Cameron Mason (Construction).
Peter said: "We are delighted to support our long standing client, Harwell Campus, on this ground breaking development and all of the associated construction work streams. We wish Harwell Campus and their contractor, Glencar Construction, the best of luck during the construction phase."
Share insightLinkedIn X Facebook Email to a friend Print